AIDIAN
LIVE

Serial Number

79270408

Owner

AIDIAN OY

Attorney

Kazuyo Morita

Filing Date

May 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AIDIAN Trademark

Serial Number: 79270408 • Registration: 6187185

AIDIAN is a trademark filed by AIDIAN OY on May 17, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 37 (Building & Construction). The application is currently registered and active.

Owner Contact Info

AIDIAN OY (13 trademarks)

KOIVU-MANKKAAN TIE 6 B
ESPOO 02200 , FI

Entity Type: 03

Trademark Details

Filing Date

May 17, 2019

Registration Date

November 3, 2020

Published for Opposition

August 18, 2020

Goods & Services

Chemical preparations for medical use, namely, for detecting infectious diseases, disorders, proteins, diabetes management, hormones, hygiene, viruses, bacteria, organs and blood; diagnostic preparations for medical use; diagnostic testing materials for medical use, namely, medical diagnostic reagents and assays for testing body fluids; diagnostic substances for medical purposes; pharmaceutical preparations for the treatment of bacterial infections; medical diagnostic reagents; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, faeces analysis; diagnostic reagents for medical purposes; medical diagnostic reagents; diagnostic preparations for medical purposes; diagnostic kits comprising diagnostic reagents, monoclonal antibodies and buffers for medical use; reagents for medical purposes; chemical reagents for medical purposes; cartridges containing reagents for use in calibrating portable blood analyzers

Diagnostic preparations for use in laboratories and for research use; chemical products, namely, diagnostic reagents for scientific use; diagnostic preparations, other than for medical use; diagnostic testing materials, namely, diagnostic test kits comprised of chemical probes and buffers for use in laboratory tests and hygiene tests, other than for medical use; diagnostic reagents for laboratory use; DNA primers for laboratory use; chemicals used to extract nucleic acid from biological specimens, other than for medical use; reagents in the nature of polymerase and buffers for use in the biotechnology field; chemicals for use as DNA extraction controls, other than for medical use; chemicals for use as RNA extraction controls, other than for medical use; negative controls, namely, negative control solutions for use in laboratory tests; calibrating solutions, namely, calibrating fluids for blood analyzers

Installation, repair and maintenance of medical apparatus and instruments; installation, repair and maintenance of medical diagnostic apparatus and instruments; providing information and consultation relating to the installation, repair and maintenance of medical apparatus and instruments; providing information and consultation relating to the installation, repair and maintenance of medical diagnostic apparatus and instruments

Diagnostic apparatus for medical and veterinary purposes for testing infectious diseases, disorders, diabetes management, proteins, hormones, hygiene, viruses, bacteria, organs and blood; medical apparatus and instruments for diagnostic use, namely, apparatus and instruments for medical diagnostic testing in the fields of point-of-care, near-patient-testing, infectious diseases, sepsis, hematology, cardiovascular diseases, diabetes management, cancer, bone and tissue disorders, tissue-based diagnostic testing, cytology and cell-based testing; electronic apparatus for medical diagnosis, namely, electromagnetic medical diagnostic imaging apparatus; medical apparatus and instruments for testing bodily fluids; blood, tissue, mucosa and faeces testing apparatus, namely, blood and mucosa, tissue, faeces sampling tubes; medical devices for use in treating or diagnosing infectious diseases, sepsis, hematology, cardiovascular diseases, diabetes management, cancer, bone and tissue disorders; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; laboratory equipment for use in the field of medical diagnostics; medical DNA sequencers for medical diagnostic purposes; medical diagnostic device, namely, a system comprising a hand-held meter, lancets, test strips and control solution for infectious diseases, sepsis, hematology, cardiovascular diseases, diabetes management, cancer, bone and tissue disorders; replacement parts and fittings for all the aforesaid goods

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 3, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 3, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 3, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 28, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 22, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 22, 2020 GNFR
FINAL REFUSAL WRITTEN
Jun 22, 2020 CNFR
DATA MODIFICATION COMPLETED
Jun 22, 2020 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2020 CRFA
ASSIGNED TO LIE
May 28, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2020 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 1, 2020 ADCH
REFUSAL PROCESSED BY IB
Dec 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 21, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 21, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 2, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 1, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 31, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2019 REPR